Introduction of the Founder
Han Jie
Ph.D. in Chemical Engineering (China) and Materials Science (USA)
Founder, Chairman and General Manager of Sunvou (2008 – ) Talent introduced by the state in 2004 / Talent introduced by Wuxi in 2008 / Innovative Talent of the Ministry of Science and Technology in 2017
Over 100 Patents, Over 100 Papers, and 4 Monographs in Nanotechnology
Won more than 10 awards for innovation and entrepreneurship, including the Feynman Nanotechnology Award in 1997
Company Introduction
SUNVOU is global leader in breath molecular diagnosis technology innovations, with the most granted patents, the most registered products, 400+ peer reviewed publications, 5,000+ devices in hospitals and 15 million+ tests from 2012 to 2024, founded by formal NASA, Honeywell, CISCO and Huawei scientists & engineers, joined by MIT and UC Berkeley graduates.
Development History
2008-2010
- The Company was Established
- Established Class II medical electronic equipment production line andsupporting quality management system
- Obtained Class Il Medical Device Production License of the PRC
- Conferred with “Rising Star” Honorary Title
- Secured the first Medical Device Registration Certificate for its products
2011-2013
- Attained EU CE Certification
- Acquired ISO 13485:2003 and ISO 9001:2008 Quality Management System Certification Certificates
- Conferred with the “Future Star” Honorary Recognition
- Granted the Title of “National High-Tech Enterprise”
- Secured the Second Prize in the Startup Track of the 2nd China Innovationand Entrepreneurship Competition
2014-2016
- Obtained 3 new registration certificates for medical device products
- Recognized as an Advanced Demonstration Unit for StandardizedManagement of Enterprise Intellectual Property in Jiangsu Province
- Listed on the NEEQ, Stock Code: 835730
2017-2018
- Awarded the title of “Wuxi AAA-Level Enterprise Honoring Contracts andKeeping Promises”
- Awarded the honorary title of “Gazelle Enterprise of Southern JiangsuNational Independent Innovation Demonstration Zone”
- Sunvou’s product portfolio has expanded to 4 major series, with a total of 21registered products, entering over 1,000 hospitals across 30 provinces andmunicipalities nationwide
2019-2021
- 9 new registered products added, total reaching 38; maintains global No.1 innumber of products in exhalation diagnosis field
- Named “Wuxi Exhaled Molecular Diagnosis Engineering TechnologyResearch Center”
- Topping-out of Sunvou’s new building
- “Expert Consensus on Pediatric Exhaled Nitric Oxide Detection & ClinicalApplication (2021)” (based on Sunvou’s tech) officially released in ChineseJournal of Practical Pediatrics
- “Chinese Expert Consensus on Exhaled Nitric Oxide Detection Tech & AirwayDisease Application” (based on Sunvou ‘s tech) officially released at “2021Chronic Airway Disease Management Summit & 2nd China Airway DiseaseCongress”
2022-Present
- Recognized as a “Jiangsu Provincial Specialist, Refined, Characteristic, andInnovative Little Giant Enterprise”
- Awarded the honor of “Outstanding Integrity Unit” among Jiangsu ProvincialMedical Device Manufacturers for the 2021-2023 period
- Accredited as a “Wuxi Municipal Enterprise Technology Center”
- Shortlisted for the “China Brand Innovation and Development Project”
Honors and Qualifications
Globally holds the largest number of patents
Data Source: IncoPat Patent Database, 2024
Medical devices with the most global registrations
Data Source: FDA, PMDA, TGA, NMPA & CE Notify Bodies, 2023